Salivary Gland Dysfunction Secondary to Cancer Treatment
The number of cancer survivors are increasing and so are the oral toxicities from cancer therapy. Most patients receiving treatment for cancer develop some form of oral adverse events including, but not limited to, mucositis, opportunistic infections, dry mouth, and/or osteonecrosis of the jaw. One...
Main Authors: | Anette Vistoso Monreal, Gregory Polonsky, Caroline Shiboski, Vidya Sankar, Alessandro Villa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oral Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/froh.2022.907778/full |
Similar Items
-
Factors associated to salivary flow alterations in dry mouth female patients
by: Vanessa Leal Scarabelot, et al. -
Effect of Xerostomia and Hyposalivation on Quality of Life in Patients Receiving Chemotherapy
by: Tahereh Molania, et al.
Published: (2021-02-01) -
Characterization and Pathogenic Speculation of Xerostomia Associated with COVID-19: A Narrative Review
by: Hironori Tsuchiya
Published: (2021-11-01) -
Dry mouth effects from drugs used for depression, anxiety, schizophrenia and bipolar mood disorder in adults: systematic review
by: Cherilyn Xue Wei Teoh, et al.
Published: (2023-03-01) -
Salivary Pacemakers: A review
by: Shriprasad Sarapur, et al.
Published: (2012-01-01)